Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125849031 | 12584903 | 1 | I | 20160210 | 20160714 | 20160722 | 20160722 | PER | US-ASTRAZENECA-2016SE77735 | ASTRAZENECA | 19230.00 | DY | F | Y | 63.90000 | KG | 20160723 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125849031 | 12584903 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 3.6MG UNKNOWN | U | 19726 | 3.6 | MG | IMPLANT | ||||||
| 125849031 | 12584903 | 2 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Oral | UNKNOWN | U | 0 | TABLET | ||||||||
| 125849031 | 12584903 | 3 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | 0 | 125 | MG | CAPSULE | QD | |||||||
| 125849031 | 12584903 | 4 | C | XGEVA | DENOSUMAB | 1 | Subcutaneous | 0 | 120 | MG | INJECTION | ||||||||
| 125849031 | 12584903 | 5 | C | LATROZOLE | 2 | 0 | 2.5 | MG | QD | ||||||||||
| 125849031 | 12584903 | 6 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 125849031 | 12584903 | 7 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | TAKE 1 TABLET EVERY DAY BEFORE BREAKFAST | 0 | TABLET | |||||||||
| 125849031 | 12584903 | 8 | C | FEMARA | LETROZOLE | 1 | Oral | 0 | 2.5 | MG | TABLET | QD | |||||||
| 125849031 | 12584903 | 9 | C | FASLODEX | FULVESTRANT | 1 | Intramuscular | INTRAMUSCULAR ROUTE EVERY MONTH AS 2 EQUALLY DIVIDED INJECTIONS, ONE IN EACH BUTTOCK, OVER | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125849031 | 12584903 | 3 | Breast cancer metastatic |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125849031 | 12584903 | Bone pain | |
| 125849031 | 12584903 | Depression | |
| 125849031 | 12584903 | Drug intolerance | |
| 125849031 | 12584903 | Fatigue | |
| 125849031 | 12584903 | Gingival swelling | |
| 125849031 | 12584903 | Hot flush | |
| 125849031 | 12584903 | Nausea | |
| 125849031 | 12584903 | Neutrophil count decreased | |
| 125849031 | 12584903 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125849031 | 12584903 | 1 | 20151217 | 0 | ||
| 125849031 | 12584903 | 3 | 20160114 | 0 | ||
| 125849031 | 12584903 | 4 | 20151217 | 0 | ||
| 125849031 | 12584903 | 6 | 20120229 | 0 | ||
| 125849031 | 12584903 | 7 | 20160512 | 0 | ||
| 125849031 | 12584903 | 8 | 20151217 | 0 | ||
| 125849031 | 12584903 | 9 | 20151217 | 0 |